Market Currents
Edwards Lifesciences (EW -5.5%) slips after J.P. Morgan says sales of the company's new Sapien...
-
Friday, April 13, 2012, 3:56 PM ETEdwards Lifesciences (EW -5.5%) slips after J.P. Morgan says sales of the company's new Sapien heart valve will be weaker than expected because it is hard to identify patients ideal for the product. The firm believes EW is likely to cut Q1 and 2012 sales guidance because Sapien sales in the U.S. have been disappointing.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
